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3. As for the testing procedure, we indeed used datasets
non-overlapping with those upon which the training
was run; this is necessary to avoid unwanted biases.
Furthermore, as described in Dal Moro et al.2 we chose
a number of non-intersecting training/testing sets by
properly ‘shuffling’ the whole data set, and took
averages of the results, thus validating the model.
4. The above canonical procedure has been performed
also for the logistic regression and support vector
machine algorithms, modulo the differences in struc-
ture, in the entity and number of parameters
considered, and in the training scheme employed for
the particular methodology. The collection of results
are finally compared in Dal Moro et al.2 Figure 1.
In conclusion, although we understand that for special
problems the ANN may still yield reasonable results, we
argue that in general (from a theoretical perspective) and
in particular (for the considered case study) support vector
machine indeed outperform ANN.
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To the Editor: Your editorial ‘Evidence-based politics of
salt and blood pressure’1 distorts both the scientific debate
among leading experts and contains significant factual errors
about the Salt Institute and our Data Quality Act challenge in
Salt Institute v. Leavitt.
You accuse the Salt Institute of having ‘invent(ed)
controversy’ on the question of whether the entire population
should be advised to reduce dietary salt. The Cochrane
Collaboration, the prestigious consortium of medical scien-
tists who invented and defined the practice of ‘evidence-
based medicine,’ rejects the evidence for a population
intervention.2 The current president of the International
Society of Hypertension rejects a ‘one size fits all’ approach.3
The founder of the American Society of Hypertension, a Time
magazine cover story subject for his seminal research, rejects
the idea that evidence justifies universal salt reduction.4 In
1998, investigative reporter Gary Taubes won the national
prize from the National Association of Science Writers for his
article in Science on ‘The (political) science of salt’5
chronicling National Heart, Lung and Blood Institute’s
efforts to quell scientific dissent. We did not ‘invent’ this
controversy among leading medical researchers.
You discuss our lawsuit, Salt Institute v. Leavitt, which
we brought jointly with the US Chamber of Commerce,
speculating disparagingly: ‘Their aim is probably to extract
data on a few patients and show that these few did not
respond to decreased salt intake with lowering blood
pressure.’ Utter nonsense. Our petition6 sought correction
of a statement by the National Heart, Lung and Blood
Institute that the DASH-Sodium study proved that every
American would benefit from lowering dietary salt. We
simply sought basic statistics, no patient data. Most scientists
would agree with us that the statistics we sought – blood
pressure means and standard deviations – are necessary to
interpret the findings, yet these have yet to be produced
5 years after the first report was published, despite a flood
of other published articles, one admitting that there is
no statistically significant association in six of the eight
subgroups.7 As the government intended to use the study to
support the Dietary Guidelines for Americans, the question is
clearly important. The government should meet the same
standards of scientific justification as private parties. And as
we have seen in the Vioxx debacle, even the higher private
sector standard may not be high enough.
1. http://www.nature.com/ki/journal/v69/n10/pdf/5001520a.html.
2. Hooper L, Bartlett C, Davey Smith G et al. Systematic review of long term
effects of advice to reduce dietary salt in adults. BMJ 2002; 325: 628–636
(http://bmj.com/cgi/reprint/325/7365/628.pdf).
3. Cohen H, Hailpern S, Fang J et al. Sodium intake and mortality in the
NHANES II follow-up study. Am J Med 2006; 119, 275.e7–275.e14 (http://
www.amjmed.com/article/PIIS0002934305010466/abstract).
4. Hypertension: conquering the quiet killer. Time Magazine. 13 January,
1975 (http://www.time.com/time/covers/0,16641,19750113,00.html).





7. Bray GA, Vollmer W, Sacks F et al. A further subgroup analysis of the
effects of the DASH diet and three dietary sodium levels on blood
pressure: results of the DASH-Sodium Trial. Am J Cardiol 2004; 94:
222–227.
RL Hanneman1
1Salt Institute, Alexandria, Virginia, USA
Correspondence: RL Hanneman, Salt Institute, 700 N. Fairfax Street, Suite
600, Alexandria, Virginia 22314-2040, USA. E-mail: dick@saltinstitute.org
Editorial on the politics of salt and
blood pressure
Kidney International (2006) 71, 85–86. doi:10.1038/sj.ki.5001951
To the Editor: The editorial on the politics of salt and blood
pressure was exceptionally prescient in recognizing the
influence of a trade lobby, the Salt Institute, on policies
(Kidney Int 2006; 69: 1707–1708). In one regard, though, the
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